2014年生物科技类股票涨幅惊人
2014年，生物科技股票表现再一次显著跑赢大市。IBB基金（ iShares Nasdaq Biotechnology ETF）全年收益34%，而小盘股权重较大的XBI基金（SPDR S&P Biotech ETF）全年收益超过43%，同期标普500指数仅上涨11%。
股价涨幅最大的10支生物科技股票：
1. Avanir Pharmaceuticals (AVNR) 405%
2. OvaScience (OVAS) 384%
3. Agios Pharmaceuticals (AGIO) 384%
4. Bluebird Bio (BLUE) 368%
5. Receptos (RCPT) 323%
6. TG Therapeutics (TGTX) 306%
7. Prosensa (RNA) 302%
8. Pernix Therapeutics (PTX) 273%
9. Achillion Pharma (ACHN) 269%
10. Amicus Therapeutics (FOLD) 254%
2014年有28只股票市值增加到10亿美元以上，市值增幅最大的十支股票如下：
1. Receptos $3.8 billion 613%
2. OvaScience $1.05 billion 574%
3. Avanir Pharma $3.3 billion 543%
4. Bluebird Bio $2.9 billion 476%
5. Agios Pharma $4.1 billion 450%
6. Achillion Pharma $1.2 billion 283%
7. PTC Therapeutics $1.5 billion 277%
8. Chimerix $1.4 billion 268%
9. Tetraphase $1.2 billion 258%
10. Horizon Pharma $1.5 billon 205%
不过，有喜就有忧，以下这些股票是生物科技类股票表现最差的：
1. Nymox (NYMX) -93%
2. Elbit Imaging (EMITF) -92%
3. Sophiris Bio (SPHS) -85%
4. WaferGen BioSystems (WGBS) -85%
5. Rock Creek Pharmac (RCPI) -84%
6. Nanosphere (NSPH) -83%
7. Cyclacel Pharma (CYCC) -83%
8. Cytori Therapeutics (CYTX) -81%
9. Regado BioSciences (RGDO) -81%
10. BioLife Solutions (BLFS) -81%
